drugset / Trial / NCT05942365
A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam
NaSingle-groupOpen-labelBasic science
Summary
This study is a single-center, open label phase I clinical study to characterize the DDIs potential of ZSP1273 With Warfarin and Midazolam in Chinese healthy participants. This study also aims to evaluate the safety and tolerability of ZSP1273 in the presence of Warfarin and Midazolam.
Timeline
- Start
- 2023-06-25
- Primary completion
- 2023-07-21
- Completion
- 2023-08-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midazolam | Small molecule | — | Oral |
| Subject | Onradivir | Small molecule | — | — |
| Subject | Warfarin | Small molecule | — | Oral |
Indications
No indication recorded.